Related Experiment Video
Updated: Feb 24, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere
Islam Eid1, Mohamed M Elsebaei1, Haroon Mohammad2
1Department of Organic Chemistry, College of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.
Abstract:
The promising antibacterial potency of arylthiazole antibiotics is offset by their limited activity against intracellular bacteria (namely methicillin-resistant Staphylococcus aureus (MRSA)), similar to many clinically-approved antibiotics. The failure to target these hidden pathogens is due to the compounds' lack of proper characteristics to accumulate intracellularly. Fine tuning of the size and polar-surface-area of the linking heteroaromatic ring provided a new series of 5-thiazolylarylthiazoles with balanced properties that allow them to sufficiently cross and accumulate inside macrophages infected with MRSA. The most promising compound 4i exhibited rapid bactericidal activity, good metabolic stability and produced over 80% reduction of intracellular MRSA in infected macrophages.
Insights
New arylthiazole antibiotics show potent activity against intracellular methicillin-resistant Staphylococcus aureus (MRSA). Optimized compounds effectively accumulate within macrophages, reducing MRSA by over 80% and offering hope against resistant bacterial infections.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Microbiology
Background:
- Arylthiazole antibiotics show promise but struggle against intracellular pathogens like methicillin-resistant Staphylococcus aureus (MRSA).
- Many antibiotics fail to target intracellular bacteria due to poor cellular accumulation.
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to its resistance to conventional treatments.
Purpose of the Study:
- To develop novel arylthiazole derivatives with enhanced intracellular accumulation for targeting MRSA.
- To investigate the structure-activity relationship of 5-thiazolylarylthiazoles for improved antibacterial efficacy.
Main Methods:
- Synthesized a new series of 5-thiazolylarylthiazoles by fine-tuning the linking heteroaromatic ring's size and polar-surface-area.
- Evaluated the compounds' ability to cross cell membranes and accumulate in MRSA-infected macrophages.
- Assessed antibacterial activity, metabolic stability, and reduction of intracellular MRSA.
Main Results:
- Optimized compounds demonstrated improved properties for intracellular accumulation in macrophages.
- Compound 4i exhibited rapid bactericidal activity and good metabolic stability.
- Compound 4i achieved over 80% reduction of intracellular MRSA in infected macrophages.
Conclusions:
- Tailored 5-thiazolylarylthiazoles can effectively target intracellular MRSA by enhancing cellular accumulation.
- Compound 4i represents a promising lead candidate for developing new therapies against MRSA infections.
- This study highlights the potential of medicinal chemistry in overcoming antibiotic resistance challenges.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Archaeal Cell Wall

